- The inquiry concerns the applicable VAT rate for specific ophthalmic medical devices produced and distributed by ALFA and BETA.
- The products include various eye sprays and drops, all designed for lubrication, hydration, and relief of ocular discomfort, suitable for use with or without contact lenses.
- The products are formulated with ingredients such as liposomes, cross-linked hyaluronic acid, plant extracts, and are often preservative-free to minimize adverse reactions.
- The devices are intended for treating dry eye syndrome, ocular irritation, and for maintaining or restoring the tear film and ocular surface homeostasis.
Source: agenziaentrate.gov.it
Note that this post was (partially) written with the help of AI. It is always useful to review the original source material, and where needed to obtain (local) advice from a specialist.
Latest Posts in "Italy"
- Italy Allows SPVs to Recover Input VAT on Merger Leveraged Buyout Transaction Costs
- Italy: Supreme Court Confirms VAT Refund from Treasury for Long-Term Insolvent Customer Debts
- VAT Return: Calculating Deductible Tax and Pro Rata Results in Section VF for 2025
- 2025 VAT Balance Payment Deadline and Options for Deferral or Installments
- VAT on Professional Fees from a Dissolved Company: Effects of Relocation and VAT Closure














